Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life
Abstract Background Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined by left ventricular hypertrophy that cannot be explained by another cardiac or systemic disease. There is a general lack of knowledge about patients' perspectives on the symptoms and day-to-day limita...
Saved in:
Main Authors: | Erica Zaiser (Author), Amy J. Sehnert (Author), Ashley Duenas (Author), Sara Saberi (Author), Ella Brookes (Author), Matthew Reaney (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration
by: Peter Chang, et al.
Published: (2024) -
Recommendation of mavacamten posology by model‐based analyses in adults with obstructive hypertrophic cardiomyopathy
by: Samira Merali, et al.
Published: (2024) -
Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
by: Gabrielle Norrish, et al.
Published: (2021) -
Management of Hypertrophic Cardiomyopathy
by: Alan D. Enriquez, et al.
Published: (2014) -
Neonatal hypertrophic cardiomyopathy with dyspnoea as the first symptom: a case report
by: Xiaoxia Li, et al.
Published: (2023)